Sign In
Buy ADMA
$8.69
+0.120 (+1.40%)
At Close: Jun 23, 2026
New York, New York and New Orleans, Louisiana--(Newsfile Corp. - June 19, 2026) - Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., notifies i
SAN DIEGO, June 19, 2026 (GLOBE NEWSWIRE) -- The law firm of Robbins Geller Rudman and Dowd LLP announces that purchasers or acquirers of ADMA Biologics, Inc. (NASDAQ: ADMA) publicly traded securities
NEW YORK, June 19, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of ADMA Biologics, Inc. (NASDAQ: ADMA) between August 9, 2024 and M
NEW YORK, June 19, 2026 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of ADMA Biologics, Inc. (NASDAQ: ADMA).
ADMA Investors Have Opportunity to Lead ADMA Biologics, Inc. Securities Fraud Lawsuit with the Schall Law Firm
09:56am, Friday, 19'th Jun 2026
LOS ANGELES, June 19, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against ADMA Biologics, Inc. (“ADMA”
ADMA Biologics (ADMA) Faces Securities Fraud Class Action after Channel Stuffing Allegations Cause 29% Stock Drop – Investors Notified to Contact BFA Law
New York, New York and New Orleans, Louisiana--(Newsfile Corp. - June 18, 2026) - Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., notifies i
ADMA Biologics, Inc. (ADMA) Class Action Lawsuit: Investors Face August 10, 2026, Deadline
02:00pm, Thursday, 18'th Jun 2026
Did you buy ADMA securities between August 9, 2024 and March 25, 2026? Affected ADMA Investor Summary Who: ADMA Biologics, Inc. (NASDAQ: ADMA) What: Securities fraud class action lawsuit filed Class P
DEADLINE ALERT for VIA, Z, and ADMA: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
12:08pm, Thursday, 18'th Jun 2026
LOS ANGELES, June 18, 2026 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded
Bronstein, Gewirtz & Grossman LLC Urges ADMA Biologics, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
12:00pm, Thursday, 18'th Jun 2026
New York, New York--(Newsfile Corp. - June 18, 2026) - Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed agains
LOS ANGELES, June 18, 2026 (GLOBE NEWSWIRE) -- Glancy Prongay Wolke & Rotter LLP reminds investors of the upcoming August 10, 2026 deadline to file a lead plaintiff motion in the class action filed on
NEW ORLEANS, June 18, 2026 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until August 10, 2026 to file lead plaintiff applications in a secu
New York, New York--(Newsfile Corp. - June 18, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of ADMA Biologics, Inc. (NASDAQ: ADMA) between August 9
ADMA Shareholder Alert: ADMA BIOLOGICS, INC. Securities Class Action Lawsuit - Investors Should Contact SueWallSt
10:07am, Thursday, 18'th Jun 2026
ADMA Biologics' SEC filings allegedly used boilerplate risk language and selective related party disclosures to obscure a channel stuffing scheme and undisclosed distributor operating from its own hea
NEW YORK, June 18, 2026 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against ADMA Biologics, Inc. ("ADMA" or the "Company") (NASDAQ: ADMA). Such investors a
